William T. Symonds
Chief Executive Officer at Altavant Sciences, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael McElhaugh | M | 50 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 15 years |
| Myrtle Potter | F | 65 |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | 3 years |
| Keith Manchester | M | 55 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | 10 years |
| Richard Henriques | M | 68 | 10 years | |
| David Hastings | M | 62 | 6 years | |
| Daniel Burgess | M | 62 | 7 years | |
| Michael Sofia | M | 66 | 10 years | |
| Karen Sims | M | 53 | 7 years | |
| P. Schaefer Price | M | 61 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | 10 years |
| Toru Kimura | M | 63 |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | - |
| Yuichiro Haruyama | M | - |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | - |
| Jebediah Ledell | M | 49 |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | 5 years |
| Robert Cook | M | 65 | 12 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Vivek Ramaswamy | M | 38 |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | 4 years |
| Michael Jeffrey Abrams | M | 68 | 8 years | |
| Koert VandenEnden | M | 45 | 3 years | |
| Herbert Conrad | M | 91 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | - |
| Elizabeth Howard | M | 70 | 7 years | |
| Gordon Earle Moore | M | 95 | 17 years | |
| Peter Lutwyche | M | 58 | 10 years | |
| Patrick T. Higgins | M | 66 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 5 years |
| Bruce Cousins | M | 63 | 5 years | |
| Donald Jewell | M | - | 7 years | |
| Richard E. T. Smith | M | 53 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 4 years |
| Ken Galbraith | M | 61 | 4 years | |
| David Dornan | M | 46 | 5 years | |
| Monica Tellado | F | 51 | 9 years | |
| Peggy Phillips | F | 70 | 1 years | |
| James M. Denny | M | 91 | 17 years | |
| Paul F. Lubetkin | M | 73 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 3 years |
| Frank Karbe | M | 55 | 8 years | |
| Jill Quigley | F | 49 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 1 years |
| Derrell Porter | M | 53 | 4 years | |
| Shao Lee Lin | M | 57 | 3 years | |
| Dennis D. Self | M | 59 | 2 years | |
| Roger Dansey | M | 67 | 1 years | |
| Tiffany Tolmie | F | - | - | |
| Tom Frohlich | M | 48 | 2 years | |
| James Heyes | M | - | 3 years | |
| Gaston Picchio | M | - | 4 years | |
| Abel de la Rosa | M | 61 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 10 years |
| Jacques Suzanne | F | 53 |
Enzyvant, Inc.
Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | 3 years |
| Smital Shah | F | 48 | 2 years | |
| Thomas Russo | M | 52 | 7 years | |
| Kenneth Lock | M | 50 | 6 years | |
| Yuan Xu | M | 56 | 1 years | |
| John Sundy | M | 62 | 6 years | |
| Rolf Carlsson | M | - | 2 years | |
| Marni Kottle | F | - | 8 years | |
| Jean Jen | F | 37 | 3 years | |
| Helia Baradarani | F | - | - | |
| Patricia Snyder-Johnson | F | - |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 1 years |
| Noreen Henig | M | 59 | 6 years | |
| Roy Baynes | M | 69 | 1 years | |
| M. Berrey | M | 57 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 5 years |
| Michael D. Rogers | M | 68 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 5 years |
| Ansbert Gadicke | M | 66 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 8 years |
| G. Steven Burrill | M | 79 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 7 years |
| Fredric D. Price | M | 78 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 3 years |
| Kevin B. Young | M | 66 | 10 years | |
| Adam Daniel Cutler | M | 50 | 2 years | |
| Alexandra Goll | M | 68 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 6 years |
| Ian MacLachlan | M | - | 6 years | |
| Susan T. Hubbard | F | - | 23 years | |
| Craig S. Gibbs | M | 61 | 21 years | |
| Paul Brennan | M | - | 5 years | |
| Alan Roemer | M | 54 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 9 years |
| Langdon L. Miller | M | 70 | 2 years | |
| David Gollaher | M | 74 | 4 years | |
| Mark Kowalski | M | 69 | 3 years | |
| Scott Ogg | M | 57 | 2 years | |
| Keith Westby | M | 49 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | 2 years |
| Maria Fardis | M | 56 | 11 years | |
| Diane Gardiner | F | - | 2 years | |
| Uri Lopatin | M | 52 | 2 years | |
| Stephen Cheng | M | - | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 76 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- William T. Symonds
- Personal Network